Your browser doesn't support javascript.
loading
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study.
Christensen, Ingrid Egeland; Jyssum, Ingrid; Tveter, Anne Therese; Sexton, Joseph; Tran, Trung T; Mjaaland, Siri; Kro, Grete Birkeland; Kvien, Tore K; Warren, David John; Jahnsen, Jørgen; Munthe, Ludvig A; Haavardsholm, Espen A; Vaage, John Torgils; Grødeland, Gunnveig; Lund-Johansen, Fridtjof; Jørgensen, Kristin Kaasen; Syversen, Silje Watterdal; Goll, Guro Løvik; Provan, Sella Aarrestad.
Afiliación
  • Christensen IE; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, P.O Box 23, Vinderen, N-0319, Oslo, Norway. Ingridegelandboe@gmail.com.
  • Jyssum I; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Ingridegelandboe@gmail.com.
  • Tveter AT; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, P.O Box 23, Vinderen, N-0319, Oslo, Norway.
  • Sexton J; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Tran TT; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, P.O Box 23, Vinderen, N-0319, Oslo, Norway.
  • Mjaaland S; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, P.O Box 23, Vinderen, N-0319, Oslo, Norway.
  • Kro GB; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Kvien TK; Norwegian Institute of Public Health, Oslo, Norway.
  • Warren DJ; Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  • Jahnsen J; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, P.O Box 23, Vinderen, N-0319, Oslo, Norway.
  • Munthe LA; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Haavardsholm EA; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
  • Vaage JT; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Grødeland G; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.
  • Lund-Johansen F; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Jørgensen KK; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Syversen SW; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Goll GL; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, P.O Box 23, Vinderen, N-0319, Oslo, Norway.
  • Provan SA; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
BMC Med ; 20(1): 378, 2022 10 05.
Article en En | MEDLINE | ID: mdl-36199139
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido